等待開盤 09-25 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:HC Wainwright & Co.:维持Gossamer Bio"买入"评级,目标价从2美元升至90美元;巴克莱:维持Ultragenyx Pharmaceutical"超配"评级,目标价从32美元升至35美元
09-22 16:25
Craig-Hallum analyst Anthony Stoss initiates coverage on Arteris (NASDAQ:AIP) with a Buy rating and announces Price Target of $30.
09-22 01:44
Arteris, Inc. granted equity awards to its CFO, Saurabh Sinha, under its 2022 Employment Inducement Incentive Plan. The awards include RSUs worth $3.7 million (142,835 shares) and PSUs worth $1 million (38,604 shares). RSUs vest over four years, with 25% after the first year and the rest quarterly. PSUs vest upon achieving $200 million revenue by 2030 and a stock price of $65 by 2031. If a change in control occurs before performance goals are met...
09-11 20:30
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.04) by 150 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $24.134 million which be...
08-07 04:13
Arteris 2026年第二季度营收2410万美元,同比增长46%;每股亏损0.30美元,自由现金流转正至862万美元。ACV加版税达9950万美元,但费用上升令亏损扩大。
08-07 01:18
Arteris (AIP) on Thursday announced the appointment of Saurabh Sinha as Chief Financial Officer, effective September 8, 2026. Sinha succeeds Nick Hawkins, who is retiring after seven years with the c...
08-06 20:57
今日重点评级关注:巴克莱:维持Snap"超配"评级,目标价从15美元升至16美元;Canaccord Genuity:维持阿梅雷斯克"买入"评级,目标价从59美元升至62美元
08-05 11:45
Roth Capital analyst Suji Desilva initiates coverage on Arteris (NASDAQ:AIP) with a Buy rating and announces Price Target of $40.
08-04 17:39
Arteris shares are trading higher. The company announced that Speedata has deployed Arteris FlexNoC technology in its Callisto processor.
07-21 23:01